Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relationships between structure and function of tissue-type plasminogen activator.

D C Rijken1

  • 1Gaubius Institute TNO, Leiden, The Netherlands.

Klinische Wochenschrift
|January 1, 1988
PubMed
Summary

Human tissue-type plasminogen activator (tPA) structure determines its function. The heavy chain binds fibrin, while the light chain activates plasminogen, crucial for blood clot breakdown.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Plasma levels of plasminogen activator inhibitor-1 and bleeding phenotype in patients with von Willebrand disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII: reply.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Increased N-terminal cleavage of alpha-2-antiplasmin in patients with liver cirrhosis.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Identification and characterization of α1 -antitrypsin in fibrin clots.

Journal of thrombosis and haemostasis : JTH·2013

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Human tissue-type plasminogen activator (tPA) is a critical enzyme in fibrinolysis.
  • Understanding its structure-function relationships is key to its therapeutic applications.

Purpose of the Study:

  • To review the structure-function relationships of human tPA.
  • To elucidate the roles of different domains within the tPA protein.

Main Methods:

  • Review of existing literature on tPA structure and function.
  • Analysis of the polypeptide chain composition and domain organization of tPA.

Main Results:

  • tPA is a 527-amino acid single polypeptide chain, cleaving into a two-chain form.
  • The heavy chain comprises finger, growth factor, and kringle domains; the light chain contains the active site.
  • The heavy chain, particularly finger and kringle 2 domains, mediates fibrin binding and stimulation, while the light chain activates plasminogen.

Conclusions:

  • The distinct domains of tPA are essential for its specific functions in fibrinolysis.
  • While the light chain activates plasminogen, the heavy chain is vital for fibrin interaction and enhanced activity.
  • Further research is needed to link hepatic clearance and inhibitor interactions to specific tPA structural domains.

Related Experiment Videos